Director Taylor Ross awarded 25,000 QT Imaging options, vesting to 2028
Rhea-AI Filing Summary
QT Imaging Holdings, Inc. director Taylor Ross was granted 25,000 stock options with an exercise price of $1.90, reported as a Section 16 Form 4 filing. The options were granted on 08/11/2025 and are exercisable for common stock.
Vesting is time-based: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, resulting in full vesting on August 15, 2028, subject to continued service. The report identifies the award as a direct beneficial ownership of 25,000 options.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director equity grant of 25,000 options at $1.90, vesting over three years; generally neutral for valuation absent company size context.
The filing shows a non-derivative grant of a stock option award convertible into 25,000 shares at a $1.90 exercise price, dated 08/11/2025. Vesting is staggered with a one-third cliff then quarterly vesting to 08/15/2028. This is a standard retention and alignment mechanism for a director. Without additional context on total outstanding shares or option pool size, the award's dilutionary impact and materiality to shareholders cannot be judged from this filing alone.
TL;DR: Compensation appears standard for board-level incentive; vesting schedule aligns retention with multi-year service.
The disclosure names Taylor Ross as the reporting person and indicates direct ownership of the granted options. The vesting schedule (one-third after ~1 year, remainder over eight quarterly installments) is a common practice to promote continued service through 08/15/2028. The Form 4 provides clear terms but does not include information about grant approvals, comparator benchmarks, or how this fits into broader governance or pay practices.